Cerebrospinal fluid p-tau217 performs better than p-tau181 as a biomarker of Alzheimer’s disease

Cerebrospinal fluid (CSF) p-tau181 (tau phosphorylated at threonine 181) is an established biomarker of Alzheimer’s disease (AD) reflecting abnormal tau metabolism in the AD brain. Here the authors demonstrate that CSF p-tau217 shows better performance as an AD biomarker than p-tau181.

מידע ביבליוגרפי

Principais autores:	Shorena Janelidze, Erik Stomrud, Ruben Smith, Sebastian Palmqvist, Niklas Mattsson, David C. Airey, Nicholas K. Proctor, Xiyun Chai, Sergey Shcherbinin, John R. Sims, Gallen Triana-Baltzer, Clara Theunis, Randy Slemmon, Marc Mercken, Hartmuth Kolb, Jeffrey L. Dage, Oskar Hansson
פורמט:	Artigo
שפה:	Inglês
יצא לאור:	Nature Portfolio 2020-04-01
סדרה:	Nature Communications
גישה מקוונת:	https://doi.org/10.1038/s41467-020-15436-0
תגים:	הוספת תג אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!